Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJersey Oil & Gas plc Regulatory News (JOG)

Share Price Information for Jersey Oil & Gas plc (JOG)

Share Price is delayed by 15 minutes
Get Live Data
101.00    0.00 (0.00%)
Bid:
96.00
Ask:
106.00
Spread: 10.00 (10.417%)
Market Cap: £32.01m
JOG Live PriceLast checked at - London Stock Exchange

Intraday Jersey Oil & Gas plc Share Chart

Licence Update

18 Aug 2021 07:00

RNS Number : 9443I
Jersey Oil and Gas PLC
18 August 2021
 

18 August 2021

 

Jersey Oil and Gas plc

("Jersey Oil & Gas", "JOG" or the "Company")

 

Licence Update

 

Jersey Oil & Gas (AIM: JOG), an independent upstream oil and gas company ‎focused on the UK Continental Shelf ("UKCS") region of the North Sea, is pleased to provide an update in respect of its licences P2497 Block 20/4c (Zermatt) and P2499 Block 21/2a (Glenn).

Further to undertaking a comprehensive technical and economic evaluation of licences P2497 and P2499 and meetings recently held with the Oil and Gas Authority ("OGA"), the OGA has confirmed that it is satisfied that the Phase A Firm Commitments for both licences have been fulfilled. JOG has decided not to progress to the next licence phase, which would have required committing to a firm well in each of these two licence areas. Accordingly, the licences will automatically cease and determine at the end of Phase A of their Initial Term on 29 August 2021. 

As announced on 3 March 2021 in our Greater Buchan Area Development Project Concept Select Update, the selected concept for the GBA Development is planned to be executed in three phases and neither Glenn nor Zermatt were included in any of these phases. In the case of Glenn, this was due to the current sub-commercial status of the Glenn and Glenn North oil discoveries and in the case of the Zermatt licence, it was after taking into account the higher ranked, drill-ready portfolio of exploration opportunities in Licence P2170 (Verbier). With Glenn and Zermatt not featuring in our GBA Development plans, this licence determination does not impact our GBA farm out process, which is ongoing.

Andrew Benitz, CEO of Jersey Oil & Gas, commented:

"JOG's management has taken the pragmatic and cost-effective decision not to proceed with firm well commitments for the non-core Glenn and Zermatt licences in the context of efficient and targeted capital allocation. JOG fully respects the OGA's Asset Stewardship Expectations which govern the delivery of exploration and appraisal work programmes, and we continue to work closely with the OGA as we progress our plans for the Company's core GBA Development project."

Enquiries:

Jersey Oil and Gas plc

 

Andrew Benitz, CEO

C/o Camarco:

Tel: 020 3757 4983

Strand Hanson Limited

James Harris

Matthew Chandler

James Bellman

 

Tel: 020 7409 3494

Arden Partners plc

Paul Shackleton

 

Tel: 020 7614 5900

 

finnCap Ltd

Christopher Raggett

Tim Redfern

Tel: 020 7220 0500

Camarco

Billy Clegg

James Crothers

Tel: 020 3757 4983

 

Notes to Editors:

Jersey Oil & Gas is a UK E&P company focused on building an upstream oil and gas business in the North Sea. The Company holds a significant acreage position within the Central North Sea referred to as the Greater Buchan Area ("GBA"), which includes operatorship and 100% working interests in blocks that contain the Buchan oil field and J2 oil discovery and an 100% working interest in the P2170 Licence Blocks 20/5b & 21/1d, that contain the Verbier oil discovery and other exploration prospects.

JOG's total GBA acreage, post 29 August 2021, is estimated by management to contain 172 million barrels of oil equivalent ("MMboe") of discovered P50 recoverable resources net to JOG, in addition to significant exploration upside potential of approximately 168MMboe of prospective resources in close proximity to the Company's planned Buchan platform. JOG has recently concluded the Concept Select phase of an FDP for the Greater Buchan Area and plans to progress into Front-End Engineering and Design (FEED) later this year.

JOG is focused on delivering shareholder value and growth through creative deal-making, operational success and licensing rounds. Its management is convinced that opportunity exists within the UK North Sea to deliver on this strategy and the Company has a solid track-record of tangible success.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFVETLIDLIL
Date   Source Headline
20th Jun 20232:15 pmRNSResult of Annual General Meeting
7th Jun 20237:00 amRNSLicence Extension & Assignment Approvals
24th May 20237:00 amRNSFinal Results for the Year Ended 31 December 2022
20th Apr 20237:00 amRNSGrant of Share Options
18th Apr 20233:39 pmRNSStandard form for notification of major holdings
6th Apr 20237:00 amRNSGreater Buchan Area Farm-out
3rd Apr 202311:10 amRNSStandard form for notification of major holdings
31st Mar 20232:05 pmRNSSecond Price Monitoring Extn
31st Mar 20232:00 pmRNSPrice Monitoring Extension
31st Mar 202311:05 amRNSSecond Price Monitoring Extn
31st Mar 202311:00 amRNSPrice Monitoring Extension
31st Mar 20239:05 amRNSSecond Price Monitoring Extn
31st Mar 20239:00 amRNSPrice Monitoring Extension
31st Mar 20237:00 amRNSGreater Buchan Area Farm-out Update
30th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20237:00 amRNSChange of Adviser
29th Nov 20227:00 amRNSLicence Extension
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:36 pmRNSPrice Monitoring Extension
4th Oct 20222:00 pmRNSPrice Monitoring Extension
23rd Sep 20222:06 pmRNSSecond Price Monitoring Extn
23rd Sep 20222:00 pmRNSPrice Monitoring Extension
23rd Sep 202211:06 amRNSSecond Price Monitoring Extn
23rd Sep 202211:00 amRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
11th Jul 20223:42 pmRNSStandard form for notification of major holdings
27th May 20224:40 pmRNSSecond Price Monitoring Extn
27th May 20224:36 pmRNSPrice Monitoring Extension
26th May 20223:57 pmRNSResult of Annual General Meeting
6th May 20227:00 amRNSDirectors’ Dealings
4th May 20222:06 pmRNSSecond Price Monitoring Extn
4th May 20222:00 pmRNSPrice Monitoring Extension
3rd May 20227:00 amRNSGrant of Share Options
29th Apr 202211:05 amRNSSecond Price Monitoring Extn
29th Apr 202211:00 amRNSPrice Monitoring Extension
28th Apr 202211:05 amRNSSecond Price Monitoring Extn
28th Apr 202211:00 amRNSPrice Monitoring Extension
28th Apr 20227:00 amRNSFinal Results for the year ended 31 December 2021
9th Mar 20222:06 pmRNSSecond Price Monitoring Extn
9th Mar 20222:00 pmRNSPrice Monitoring Extension
7th Mar 20229:05 amRNSSecond Price Monitoring Extn
7th Mar 20229:00 amRNSPrice Monitoring Extension
1st Mar 20222:00 pmRNSPrice Monitoring Extension
6th Jan 20221:54 pmRNSStandard form for notification of major holdings
16th Dec 20214:36 pmRNSHolding(s) in Company
24th Nov 20217:00 amRNSGrant of Share Options
22nd Nov 20217:00 amRNSDirectorate Changes and GBA Update
25th Oct 20217:00 amRNSExercise of Options and Director/PDMR Dealings
6th Oct 20212:06 pmRNSSecond Price Monitoring Extn
6th Oct 20212:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.